Petefészekrák: vizsgálatok itt: Peru

4 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

  Where

  Castilla, Lima

  Életkor

  18 év and over

  People

  770 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06824467 · EU 2023-508015-23-00
• 3. fázisTaking people
  A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

  Where

  Lima

  Életkor

  18 év and over

  People

  900 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT07318558 · EU 2023-508047-40-00
• 3. fázisTaking people
  Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Non-Homologous Recombination Deficiency (Non-HRD) Positive Advanced Epithelial Ovarian Cancer

  Where

  Arequipa, Lima, Wanchac

  Életkor

  18 év and over

  People

  950 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07851025 · EU 2026-526895-22-00
• 3. fázisTaking people
  Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

  Where

  Lima

  Életkor

  18 év to 60 év

  People

  3960 worldwide

  Run by

  NRG Oncology

  See details and how to joinNCT05879926